Okay, last one, weekend is nearly over.
Over at least the last 20 years, 3M's culture has been slowing decaying. Around 2019, even before the pandemic, that process dramatically, exponentially accelerated. It became a place where people were not trusted, not valued, and simply put sociopathic leaders were allowed to flourish. Coming out of the pandemic I realized is was no longer a company worth working for.
I think you overestimate the size and relative importance of Acelity relative to the rest of MSD. It is important, but in no way dominating. The Acelity fraction is only roughly 1/3rd of MSD and only around 1/5th of all of HCBG. 3M Medical has been successful in these markets far, far longer than KCI or Acelity has ever existed. Cutting HCBG free with (I hope) better leadership will ultimately do those businesses a lot of good.
I agree the earplug settlement is probably substantially complete and could have been far worse for 3M.
I cannot say the same for PFAS. 3M is already accounted for over $12B into this, multiple US states and localities are asking/suing for a lot more. Europe hasn't even really started with their demands yet. My estimate is that the $12B so far will expand by several times before PFAS is finally put in the rear-view mirror for 3M. That, combined with shrinking sales, will be the cause of RemainCo's bankruptcy.